218 related articles for article (PubMed ID: 11222541)
1. Local cone and rod system function in patients with retinitis pigmentosa.
Holopigian K; Seiple W; Greenstein VC; Hood DC; Carr RE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):779-88. PubMed ID: 11222541
[TBL] [Abstract][Full Text] [Related]
2. Yearly rates of rod and cone functional loss in retinitis pigmentosa and cone-rod dystrophy.
Birch DG; Anderson JL; Fish GE
Ophthalmology; 1999 Feb; 106(2):258-68. PubMed ID: 9951474
[TBL] [Abstract][Full Text] [Related]
3. Local cone and rod system function in progressive cone dystrophy.
Holopigian K; Seiple W; Greenstein VC; Hood DC; Carr RE
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2364-73. PubMed ID: 12091439
[TBL] [Abstract][Full Text] [Related]
4. RP cone-rod degeneration.
Heckenlively JR
Trans Am Ophthalmol Soc; 1987; 85():438-70. PubMed ID: 3447340
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
Nagy D; Schönfisch B; Zrenner E; Jägle H
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
[TBL] [Abstract][Full Text] [Related]
6. The relationship between rod perimetric thresholds and full-field rod ERGs in retinitis pigmentosa.
Birch DG; Herman WK; deFaller JM; Disbrow DT; Birch EE
Invest Ophthalmol Vis Sci; 1987 Jun; 28(6):954-65. PubMed ID: 3583634
[TBL] [Abstract][Full Text] [Related]
7. Rod visual fields in cone-rod degeneration. Comparisons to retinitis pigmentosa.
Birch DG; Anderson JL
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2288-99. PubMed ID: 2242994
[TBL] [Abstract][Full Text] [Related]
8. Normal central retinal function and structure preserved in retinitis pigmentosa.
Jacobson SG; Roman AJ; Aleman TS; Sumaroka A; Herrera W; Windsor EA; Atkinson LA; Schwartz SB; Steinberg JD; Cideciyan AV
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1079-85. PubMed ID: 19797198
[TBL] [Abstract][Full Text] [Related]
9. Unique characteristics of two types of retinitis pigmentosa patients with different rod sensitivities.
Takahashi H; Miyake Y; Horiguchi M; Tomida N; Takakuwa H
Jpn J Ophthalmol; 2005; 49(2):114-20. PubMed ID: 15838727
[TBL] [Abstract][Full Text] [Related]
10. X-linked retinitis pigmentosa: functional phenotype of an RP2 genotype.
Jacobson SG; Roman AJ; Cideciyan AV; Robey MG; Iwata T; Inana G
Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3481-92. PubMed ID: 1464493
[TBL] [Abstract][Full Text] [Related]
11. Multifocal visual evoked potentials to cone specific stimuli in patients with retinitis pigmentosa.
Holopigian K; Shuwairi SM; Greenstein VC; Winn BJ; Zhang X; Carr RE; Hood DC
Vision Res; 2005 Nov; 45(25-26):3244-52. PubMed ID: 16023698
[TBL] [Abstract][Full Text] [Related]
12. Peripheral cone dystrophy: a variant of cone dystrophy with predominant dysfunction in the peripheral cone system.
Kondo M; Miyake Y; Kondo N; Ueno S; Takakuwa H; Terasaki H
Ophthalmology; 2004 Apr; 111(4):732-9. PubMed ID: 15051206
[TBL] [Abstract][Full Text] [Related]
13. Large phase differences between L-cone- and M-cone-driven electroretinograms in retinitis pigmentosa.
Scholl HP; Kremers J
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3225-33. PubMed ID: 10967087
[TBL] [Abstract][Full Text] [Related]
14. Screen of the IMPDH1 gene among patients with dominant retinitis pigmentosa and clinical features associated with the most common mutation, Asp226Asn.
Wada Y; Sandberg MA; McGee TL; Stillberger MA; Berson EL; Dryja TP
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1735-41. PubMed ID: 15851576
[TBL] [Abstract][Full Text] [Related]
15. Rod phototransduction in retinitis pigmentosa. Distinguishing alternative mechanisms of degeneration.
Shady S; Hood DC; Birch DG
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1027-37. PubMed ID: 7730012
[TBL] [Abstract][Full Text] [Related]
16. Rod ERGs in retinitis pigmentosa and cone-rod degeneration.
Birch DG; Fish GE
Invest Ophthalmol Vis Sci; 1987 Jan; 28(1):140-50. PubMed ID: 3804644
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes of stop codon and splice site rhodopsin mutations causing retinitis pigmentosa.
Jacobson SG; Kemp CM; Cideciyan AV; Macke JP; Sung CH; Nathans J
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2521-34. PubMed ID: 8163341
[TBL] [Abstract][Full Text] [Related]
18. Atypical multifocal ERG responses in patients with diseases affecting the photoreceptors.
Greenstein VC; Holopigian K; Seiple W; Carr RE; Hood DC
Vision Res; 2004 Nov; 44(25):2867-74. PubMed ID: 15380992
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa.
Hoffman DR; Locke KG; Wheaton DH; Fish GE; Spencer R; Birch DG
Am J Ophthalmol; 2004 Apr; 137(4):704-18. PubMed ID: 15059710
[TBL] [Abstract][Full Text] [Related]
20. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
Gränse L; Ponjavic V; Andréasson S
Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
